By combining high-resolution 1H/31P-MRS with dynamic measurements of GH secretion during the OGTT, we show that GH/IGF-I axis activity is reduced in otherwise metabolically healthy individuals with NAFLD and that GH and IGF-I are both independent predictors of IHL. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.